TrialThe Journal of urology2020

Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial.

Heidi S Harvie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.